k8¿­·¢(Öйú)

ÕâÊÇÃèÊöÐÅÏ¢

ÍâÃÚÌåÑо¿

È«²¿·ÖÀà
ÁôÑÔ×Éѯ
Óë×îÐÂÏûÏ¢±£´æͬ²½
1/1
ä¯ÀÀÁ¿:
1000

ÍâÃÚÌåRNAÊý×ÖPCR·þÎñ

΢µÎʽÊý×ÖPCR¼¼Êõ²»½öÓÐЧÌá¸ßÁ˺ËËá·Ö×ÓµÄÀ©ÔöЧÂÊ£¬¶øÇÒÓÉÓÚ²ÉÓÃ΢µÎ¼ÆÊýµÄ·½·¨½øÐж¨Á¿£¬´Ó¸ù±¾ÉÏÍ»ÆÆÁË»ùÓÚÓ«¹âÇ¿¶È½øÐж¨Á¿µÄ¼¼ÊõÏÞÖÆ£¬²¢¿É¶ÔËù²âÑùÆ·ÖеĺËËá·Ö×Ó½øÐоø¶Ô¶¨Á¿¡£Êý×ÖPCRµÄ¼ì²âÁéÃô¶ÈÏà±ÈÆÕͨRT-PCRÌá¸ßÁË10-100±¶£¬Ñù±¾ÓÃÁ¿Ò²¼õÉÙÁË10±¶ÒÔÉÏ¡£
ÁãÊÛ¼Û
0.0
Ôª
Êг¡¼Û
0.0
Ôª
ä¯ÀÀÁ¿:
1000
²úÆ·±àºÅ
ÊýÁ¿
-
+
¿â´æ:
0
Á¢¼´×Éѯ
1
²úÆ·ÃèÊö

 

       Î¢µÎʽÊý×ÖPCR£¨Droplet digital PCR£©£¬ÓÖ³ÆΪ“ÓÍ°üË®PCR”»ò“ddPCR”¡£ÔÚ´«Í³µÄPCRÀ©ÔöÇ°¶ÔÑùÆ·½øÐÐ΢µÎ»¯´¦Àí£¬¼´½«º¬ÓкËËá·Ö×ӵķ´Ó¦Ìåϵ·Ö³É³ÉǧÉÏÍò¸öÄÉÉý¼¶µÄ΢µÎ£¬ÆäÖÐÿ¸ö΢µÎº¬ÓÐÒ»¸öÖÁÊý¸ö´ý¼ìºËËá°Ð·Ö×Ó¡£¾­PCRÀ©Ôöºó£¬Öð¸ö¶Ôÿ¸ö΢µÎ½øÐмì²â£¬ÓÐÓ«¹âÐźŵÄ΢µÎÅжÁΪ1£¬Ã»ÓÐÓ«¹âÐźŵÄ΢µÎÅжÁΪ0£¬¸ù¾Ý²´ËÉ·Ö²¼Ô­Àí¼°ÑôÐÔ΢µÎµÄ¸öÊýÓë±ÈÀý¼´¿ÉµÃ³ö°Ð·Ö×ÓµÄÆðʼ¿½±´Êý»òŨ¶È¡£Î¢µÎʽÊý×ÖPCR¼¼Êõ²»½öÓÐЧÌá¸ßÁ˺ËËá·Ö×ÓµÄÀ©ÔöЧÂÊ£¬¶øÇÒÓÉÓÚ²ÉÓÃ΢µÎ¼ÆÊýµÄ·½·¨½øÐж¨Á¿£¬´Ó¸ù±¾ÉÏÍ»ÆÆÁË»ùÓÚÓ«¹âÇ¿¶È½øÐж¨Á¿µÄ¼¼ÊõÏÞÖÆ£¬²¢¿É¶ÔËù²âÑùÆ·ÖеĺËËá·Ö×Ó½øÐоø¶Ô¶¨Á¿¡£Êý×ÖPCRµÄ¼ì²âÁéÃô¶ÈÏà±ÈÆÕͨRT-PCRÌá¸ßÁË10-100±¶£¬Ñù±¾ÓÃÁ¿Ò²¼õÉÙÁË10±¶ÒÔÉÏ¡£

 

 

|   k8¿­·¢(Öйú)Êý×ÖPCR·þÎñ

       »ùÓÚÊý×ÖPCRÔÚÁéÃô¶ÈÉϵľø¶ÔÓÅÊÆ£¬ÔÚÍâÃÚÌåRNAÕâÖÖng¼¶Î¢Á¿ÑùÆ·µÄ¼ì²âºÍÑé֤ʱÓÈΪÊÊÓᣵ±ÍâÃÚÌåRNAÁ¿½ÏÉÙʱ£¬Êý×ÖPCR¿ÉÒÔÔÚ0.1ngµÄ»ù´¡ÉϽøÐÐÎȶ¨¼ì²â£¬¶øÆÕͨRT-PCRµÄ¼ì²âÆðʼÁ¿Ò»°ãÔÚ1ng×óÓÒ£¬ºÜÄÑÍê³É¶à¸ö»ùÒòµÄ¼ì²â¹¤×÷¡£k8¿­·¢(Öйú)½«Êý×ÖPCRÄÉÈëµ½ÍâÃÚÌåRNAs£¨miRNA¡¢mRNA¡¢lncRNAºÍcircRNA£©²âÐòÑéÖ¤ºÍ¶ÀÁ¢¼ì²âʵÑéÖУ¬²¢½¨Á¢ÁËÑϽ÷¿É¿¿µÄ¼¼Êõ·Ïߣ¬Îª»ñµÃ¿É¿¿µÄÊý×ÖPCRÊý¾ÝÌṩÁ˱£ÕÏ£¬¾ßÌå·þÎñÁ÷³ÌÈçÏ£º

 

 

 

|    ¾­µä°¸Àý£º·¢ÏÖÍâÃÚÌåmiRNA±êÖ¾ÎSmallRNA²âÐò+Êý×ÖPCR

 

 

       ÔÚ56ÀýѪ½¬ÍâÃÚÌåÖÐͨ¹ýSmall RNA²âÐò¼¼ÊõɸÑ¡£¬Ñо¿ÈËÔ±·¢ÏÖ6ÖÖmiRNAÔÚ×Ó¹¬ÄÚĤ°©Ó뽡¿µ¶ÔÕÕ¼ä´æÔÚÏÔÖø²îÒì¡£¸Ã6ÖÖmiRNAÐγɵÄ×éºÏ¶ÔÓÚ×Ó¹¬ÄÚĤ°©µÄÕï¶ÏЧÄÜAUC´ïµ½0.983¡£½øÒ»²½Í¨¹ýÓëTCGAÊý¾Ý¿â±È¶Ô£¬·¢ÏÖÕâ6ÖÖmiRNAÔÚÖ×Áö×éÖ¯Öеıí´ïÇ÷ÊÆÓëѪ½¬ÍâÃÚÌåÒ»Ö¡£

 

       Îª½ÚÔ¼Ñù±¾£¬Ñо¿ÈËÔ±²ÉÓÃÁËÁéÃô¶È¸ü¸ßµÄ΢µÎÊý×ÖPCR¼¼Êõ£¬¶Ô202Àý¶ÀÁ¢Ñª½¬Ñù±¾½øÐÐÁËÑéÖ¤£¬½á¹ûÏÔʾ3ÖÖmiRNA¿ÉÒÔÍêÈ«ÑéÖ¤²âÐò½á¹û¡£½«Õâ3ÖÖmiRNAÓ봫ͳ±êÖ¾ÎïTBÐγÉ×éºÏ£¬Äܹ»½«×Ó¹¬ÄÚĤ°©µÄÕï¶ÏЧÄÜAUCÌá¸ßµ½0.904¡£²¢ÇÒ¶ÔÓÚÔçÆÚ£¨Stage I £©µÄ×Ó¹¬ÄÚĤ°©µÄÕï¶ÏЧÄÜAUC¿É´ïµ½0.915¡£

|   Ïà¹ØÎÄÏ×

[1]. Lanyun Zhou, Wei Wang, Fenfen Wang, et al. Plasma-derived exosomal miR-15a-5p as a promising diagnostic biomarker for early detection of endometrial carcinoma. Mol Cancer. 2021 Mar 29;20(1):57. IF=27.401

[2]. Shi-Ji Li, Zhi-Wen Cai, Hong-Fu Yang, et al. A Next-Generation Sequencing of Plasma Exosome-Derived microRNAs and Target Gene Analysis with a Microarray Database of Thermally Injured Skins: Identification of Blood-to-Tissue Interactions at Early Burn Stage. J Inflamm Res. 2021:14 6783–6798. IF=6.922

[3]Zhiwu Dong, Hongjun Gu, Qiang Guo£¬et al. Profiling of Serum Exosome MiRNA Reveals the Potential of a MiRNA Panel as Diagnostic Biomarker for Alzheimer's Disease. Mol Neurobiol. 2021 Jul;58(7):3084-3094. IF=5.590

¹Ø¼ü´Ê:
ÍâÃÚÌå
RNA
ÍâÃÚÌåmicroRNAµÄ¼ì²â¼¼Êõ
mRNA
δÕÒµ½ÏàÓ¦²ÎÊý×飬ÇëÓÚºǫ́ÊôÐÔÄ£°åÖÐÌí¼Ó
k8¿­·¢(Öйú)

µØÖ·£ºÉϺ£ÊÐãÉÐÐÇøÂÌÖÞ»·Â·396Ū5´±4²ã

µç»°£º400-869-2936£¬021-33968791

ÓÊÏ䣺support@wayenbiotech.com

´«Õ棺021-33938792

QQ£º2120485725

Õ½ÂÔºÏ×÷

Õ½ÂÔºÏ×÷

·¢²¼Ê±¼ä£º2021-08-11 17:21:10

|    Full Moon    |    RayBiotech    |    CDI    |    IZON    |    Bio-Rad    |    R&D Systems    |    IsoPlexis    |    ÄÏÄ£ÉúÎï    |    Å·Ò×ÉúÎï    |    ÆäÃ÷ÐÅÏ¢    |    ÃÀ¼ªÉúÎï    |    ÂóÌØ»æÆ×    | 

 

Ìرð˵Ã÷£º±¾ÍøËùÓÐÍøÒ³¾ùΪk8¿­·¢(Öйú)Ô­´´ÐÅÏ¢£¬×ªÔرØÐëÕ÷Çók8¿­·¢(Öйú)ͬÒ⣬²¢Í¬Ê±×¢Ã÷±¾ÍøÃû³Æ¼°ÍøÖ·¡£

רÀû´úÂë

·¢²¼Ê±¼ä£º2023-06-09 17:38:30
Copyright @ 2021 ÉϺ£k8¿­·¢(Öйú)Ò½Ò©¿Æ¼¼ÓÐÏÞ¹«Ë¾ °æȨËùÓÐ
Record »¦ICP±¸2022031428ºÅ-1
ÍøÕ¾½¨É裺ÖÐÆó¶¯Á¦ ÉϺ£
ËÑË÷
ËÑË÷
¹Ø±Õ
¿Í»§ÁôÑÔ
ÑéÖ¤Âë